Invention Grant
- Patent Title: Substituted tricyclic compounds as FGFR inhibitors
-
Application No.: US16842558Application Date: 2020-04-07
-
Publication No.: US11053246B2Publication Date: 2021-07-06
- Inventor: Liangxing Wu , Colin Zhang , Chunhong He , Liang Lu , Wenqing Yao
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington; US DE Wilmington
- Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee Address: US DE Wilmington; US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D471/14
- IPC: C07D471/14 ; C07D495/14 ; C07D471/20 ; C07D498/14 ; C07D498/22 ; C07D471/22 ; C07D491/22 ; A61P1/16 ; A61P11/00 ; A61P19/02
Abstract:
The present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
Public/Granted literature
- US20200377504A1 SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS Public/Granted day:2020-12-03
Information query
